# Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

> **NCT00367965** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 153 (actual)

## Conditions studied

- Insomnia
- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00367965
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-11
- **Final completion:** 2004-11
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367965, "Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00367965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*